Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
about
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryMultiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicideUsing Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease.Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C VirusMetabolomics and Metabolic Diseases: Where Do We Stand?Endoplasmic reticulum proteostasis in hepatic steatosis.Alternative RNA Splicing in the Pathogenesis of Liver Disease.Racial Disparity in Gastrointestinal Cancer Risk.BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosisGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease.Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression.Managing the Burden of Non-NASH NAFLD.Steatotic donor livers: Where is the risk-benefit maximized?
P2860
Q28072762-9B488518-B8A1-4496-82EC-B2F9F332A2C5Q28365177-5212DFA3-A7B3-4804-9A8F-E67675BFE3E1Q31138564-8AA21CE5-55FD-4F4A-97A2-471F4091FD6AQ33813264-EDBA98BC-0414-4186-807F-576757029039Q37286603-5C7B6559-28F3-4974-B58D-092DEE0A91E4Q38769689-8FA04FEF-B743-405A-87D5-2C250C2C4599Q38925531-2C8D0B33-08CC-4DFC-96C4-CA5B6B79A279Q39416487-252164A7-30CF-417D-BFC2-BE0C7599A984Q40083252-EC4A23C2-6E49-42AB-A97D-CCE8C186BB66Q41996948-86D93EF5-9DE0-45EF-ACF5-FE4A8F70167BQ45067817-6E29D5BD-41CC-489F-A805-21893D500979Q49813492-081417D1-A0F4-4B9B-916E-94FA0AA0E700Q50068477-6BCED6FF-1BE2-45F1-89BD-19A813B1535DQ50455460-498A36F2-5C4F-4028-8990-300216E96660Q53704720-13BEBA3F-E036-48F8-B94F-1F7B39C67BC8Q54290315-5515252F-B788-4ABB-84C7-077E2F8259AB
P2860
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@ast
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@en
type
label
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@ast
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@en
prefLabel
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@ast
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@en
P2093
P2860
P1476
Global Epidemiology of Nonalco ...... ves on US Minority Populations
@en
P2093
Adeyinka O Laiyemo
Armana Saeed
Hassan Ashktorab
Hassan Brim
Seyed-Mehdi Nouraie
Zaki A Sherif
P2860
P2888
P304
P356
10.1007/S10620-016-4143-0
P577
2016-04-01T00:00:00Z